Execs expect study to expand market for implantable heart devices

06/15/2009 | Reuters

Medical-device executives are optimistic that the market for cardiac resynchronization therapy devices and other expensive implants could double if the MADIT-CRT study yields positive results. The Boston Scientific-sponsored study aims to show that combining defibrillators with CRT devices could delay the progression of early-stage heart failure. An analyst with FAF Advisors, however, said reimbursement will play a key role in boosting the sales of the combination products.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations